ezetimibe has been researched along with Rhabdomyolysis in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Macchi, C; Magni, P; Morlotti, B; Ruscica, M; Sirtori, CR | 1 |
| Fernandes, V; Pérez, A; Santos, MJ | 1 |
| Ballantyne, CM; Brennan, DM; Bruckert, E; Ceška, R; Dent-Acosta, RE; Elliott, M; Gouni-Berthold, I; Lehman, SJ; Lepor, N; Nissen, SE; Preiss, D; Rosenson, RS; Sattar, N; Scott, R; Somaratne, R; Stein, EA; Stroes, E; Wasserman, SM | 1 |
| Chen, L; Colantonio, LD; Huang, L; Kent, ST; Kilgore, ML; Manthripragada, A; Monda, KL; Muntner, P; Rosenson, RS; Serban, MC | 1 |
| Frydrychowicz, C; Mueller, W; Pasieka, B; Petros, S; Pierer, M; Weidhase, L | 1 |
| Sundermeyer, M; Veeraputhiran, M | 1 |
| Brosteaux, C; Buclin, T; Kuntzer, T; Rodondi, N; Ruiz, J | 1 |
| Thesen, R | 1 |
| McKenney, JM | 1 |
| Amado Señaris, JA; García Unzueta, MT; Otero Martínez, M; Piedra León, M | 1 |
| Berthold, J; Krone, W | 1 |
4 review(s) available for ezetimibe and Rhabdomyolysis
| Article | Year |
|---|---|
Risk identification and possible countermeasures for muscle adverse effects during statin therapy.
Topics: Age Factors; Aged; Aged, 80 and over; Anticholesteremic Agents; Colesevelam Hydrochloride; Creatine Kinase; Drug Interactions; Drug Therapy, Combination; Dyslipidemias; Ezetimibe; Fatty Acids, Monounsaturated; Female; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Male; Muscular Diseases; Myalgia; Rhabdomyolysis; Risk Assessment; Risk Factors; Rosuvastatin Calcium; Sex Factors; Vitamin D Deficiency | 2015 |
Statin-related myotoxicity.
Topics: Clinical Trials as Topic; Comorbidity; Creatine Kinase; Cytochrome P-450 CYP3A; Dietary Supplements; Disease Management; Disease Susceptibility; Drug Interactions; Drug Substitution; Exercise; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Male; Meta-Analysis as Topic; Muscular Diseases; Rhabdomyolysis; Risk Factors | 2016 |
[Statins and muscular side-effects].
Topics: Age Factors; Aged, 80 and over; Algorithms; Anticholesteremic Agents; Azetidines; Biopsy; Cardiovascular Diseases; Creatine Kinase; Ezetimibe; Female; Humans; Life Style; Male; Muscle, Skeletal; Muscular Diseases; Myositis; Pain; Primary Prevention; Randomized Controlled Trials as Topic; Retrospective Studies; Rhabdomyolysis; Secondary Prevention; Sex Factors; Ubiquinone | 2010 |
Pharmacologic options for aggressive low-density lipoprotein cholesterol lowering: benefits versus risks.
Topics: Allylamine; Anticholesteremic Agents; Atorvastatin; Azetidines; Cholesterol, LDL; Clinical Trials as Topic; Colesevelam Hydrochloride; Coronary Artery Disease; Drug Therapy, Combination; Ezetimibe; Fluorobenzenes; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Muscular Diseases; Niacin; Pyrimidines; Pyrroles; Rhabdomyolysis; Risk Factors; Rosuvastatin Calcium; Simvastatin; Sulfonamides; Treatment Outcome | 2005 |
1 trial(s) available for ezetimibe and Rhabdomyolysis
| Article | Year |
|---|---|
Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance: The GAUSS-3 Randomized Clinical Trial.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Anticholesteremic Agents; Atorvastatin; Biomarkers; Cholesterol, LDL; Creatine Kinase; Cross-Over Studies; Double-Blind Method; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Middle Aged; Muscular Diseases; Myalgia; Myositis; Rhabdomyolysis; Time Factors | 2016 |
6 other study(ies) available for ezetimibe and Rhabdomyolysis
| Article | Year |
|---|---|
Algorithms to Identify Statin Intolerance in Medicare Administrative Claim Data.
Topics: Aged; Aged, 80 and over; Algorithms; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Medicare; Medication Adherence; Retrospective Studies; Rhabdomyolysis; United States | 2016 |
Colchicine triggered severe rhabdomyolysis after long-term low-dose simvastatin therapy: a case report.
Topics: Acute Kidney Injury; Aged; Colchicine; Ezetimibe; Gout Suppressants; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Obesity; Rhabdomyolysis; Simvastatin; Treatment Outcome | 2017 |
Rhabdomyolysis resulting from pharmacologic interaction between erlotinib and simvastatin.
Topics: Aged; Amlodipine; Anti-Inflammatory Agents, Non-Steroidal; Anticholesteremic Agents; Antihypertensive Agents; Aspirin; Atenolol; Azetidines; Carcinoma, Non-Small-Cell Lung; Coronary Artery Disease; Drug Interactions; Erlotinib Hydrochloride; Ezetimibe; Female; Humans; Hyperlipidemias; Hypertension; Lung Neoplasms; Neoplasm Recurrence, Local; Protein Kinase Inhibitors; Quinazolines; Rhabdomyolysis; Simvastatin; Tomography, X-Ray Computed | 2008 |
[Innovation instead of imitation -- news in drug therapy -- regarding the contribution in DMW 13/2005].
Topics: Acute Disease; Anticholesteremic Agents; Azetidines; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Ezetimibe; Humans; Pancreatitis; Rhabdomyolysis; Thrombocytopenia | 2005 |
[Rhabdomyolysis associated to combined ezetimibe-statin treatment].
Topics: Adult; Alcohol Drinking; Anticholesteremic Agents; Atorvastatin; Azetidines; Drug Therapy, Combination; Ezetimibe; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Pyrroles; Rhabdomyolysis; Risk Factors; Time Factors | 2007 |
[Type 1 diabetes: what are the alternatives for lowering cholesterol levels with statins?].
Topics: Anticholesteremic Agents; Azetidines; Diabetes Mellitus, Type 1; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Middle Aged; Rhabdomyolysis | 2007 |